✦ LIBER ✦

O-097 A randomized phase III trial of six versus four cycles ofchemotherapy: Optimal duration of chemotherapy in advanced non-small-cell lung cancer: Korea cancer study group experience

✍ Scribed by Park, J.; Kim, S.; Jang, J.; Cho, E.; Yang, S.; Choi, J.; Heo, D.; Shin, S.; Yun, Y.; Park, K.

Book ID: 118572645
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 266 KB
Volume: 49
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(05)80231-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine versus gemcitabine/carboplat

Gemcitabine versus gemcitabine/carboplatin in advanced non–small cell lung cancer: Preliminary findings in a phase III trial of the Swedish Lung Cancer Study Group

✍ Christer Sederholm 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 125 KB

Randomized International Phase III Trial

Randomized International Phase III Trial of ERCC1 and RRM1 Expression-Based Chemotherapy Versus Gemcitabine/Carboplatin in Advanced Non-Small-Cell Lung Cancer

✍ Bepler, G.; Williams, C.; Schell, M. J.; Chen, W.; Zheng, Z.; Simon, G.; Gadgeel 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 184 KB

Docetaxel Versus Docetaxel/Cisplatin in

Docetaxel Versus Docetaxel/Cisplatin in Patients with Advanced Non–Small-Cell Lung Cancer: Preliminary Analysis of a Multicenter, Randomized Phase III Study

✍ V. Georgoulias; A.G. Pallis; C. Kourousis; A. Alexopoulos; A. Ardavanis; A. Agel 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 150 KB

PIONEER: A Phase III Randomized Trial of

PIONEER: A Phase III Randomized Trial of Paclitaxel Poliglumex Versus Paclitaxel in Chemotherapy-Naive Women with Advanced-Stage Non-Small-Cell Lung Cancer and Performance Status of 2

✍ Kathy S. Albain; Chandra P. Belani; Philip Bonomi; Kenneth J. O'Byrne; Joan H. S 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 145 KB

PD-065 Duration of chemotherapy in non-s

PD-065 Duration of chemotherapy in non-small-cell lung cancer: Multicenter, randomized, prospective clinical trial comparing 4 vs 6 cycles of carboplatin and gemcitabine. (Portuguese Lung Cancer Study Group 03/03)

✍ Barata, F.; Parente, B.; Teixeira, E.; Nogueira, F.; Fernandes, A.; Cunha, J.; A 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 149 KB

O-90 Randomised phase III trial of docet

O-90 Randomised phase III trial of docetaxel/carboplatin vs. MIC/MVP chemotherapy in inoperable advanced non-small cell lung cancer (NSCLC) — A British thoracic oncology group (BTOG) trial

✍ Booton, Richard; Ascroft, Linda; Stout, Ron; Lorigan, Paul; Faivre-Finn, Corinne 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 182 KB